Replies to post #705 on Vascular Biogenics Ltd (VBLT)

[wcopeland]

That is a great point Oren. Many companies are highly selective in their early trials and it contributes to late-stage failures. The research, clinical guidance, and business strategy behind VBLT all seem very solid.